← Browse by Condition
Medical Condition

bronchiolitis

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for bronchiolitis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — bronchiolitis Clinical Trials

How many clinical trials are currently recruiting for bronchiolitis?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for bronchiolitis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for bronchiolitis?
bronchiolitis research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a bronchiolitis clinical trial?
Eligibility criteria for bronchiolitis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
Montefiore Medical Center 1 trial
Nemours Children's Clinic 1 trial
National Jewish Health 1 trial
Elsan 1 trial

Recruiting Clinical Trials

NCT06053684
Recruiting
Non-Invasive Ventilation Versus Neurally-Adjusted Ventilatory Assistance (NAVA) for the Treatment of Bronchiolitis
Enrollment
130 pts
Location
United States
Sponsor
Montefiore Medical Center
View Trial →
NCT06946264 Phase 3
Recruiting
Characterization of Bronchodilator Response in Children With Bronchiolitis Using Phenotypic and Genotypic Features
Enrollment
400 pts
Location
United States
Sponsor
Nemours Children's Clinic
View Trial →
NCT03035097
Recruiting
Deployment-Related Lung Disease Research Database and Biorepository
Enrollment
500 pts
Location
United States
Sponsor
National Jewish Health
View Trial →
NCT06842238
Recruiting
Descriptive Study of the Initial Management of Young Children With Moderate Acute BRONCHiotitis With Home Hospitalisation
Enrollment
40 pts
Location
France
Sponsor
Elsan
View Trial →

Related Conditions

bronchodilator agents (1) bronchiolitis acute (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology